Bluejay Diagnostics (NASDAQ:BJDX) soars 47% premarket; warrant financing still subject to conditions
NEW YORK, August 5, 2026, 06:08 EDT - Shares of Bluejay Diagnostics rose 47% in premarket trading, while warrant funding for the company continues to depend on certain conditions.
